Skip to main content
Lydia Visser
PhD

My research in the Pathology department is mainly focused on immunological aspects of B-cell lymphoma. I study interactions of tumor cells with the microenvironment, and signaling pathways in Hodgkin lymphoma and non-Hodgkin lymphomas.

Hodgkin’s lymphoma associated T-cells exhibit a transcription factor profile consistent with distinct lymphoid compartments
Background: Hodgkin’s lymphoma (HL) is characterised by an ineffective immune response that is predominantly mediated by CD4(+) T-cells. Aims: To analyse the expression of the key regulatory T-cell transcription factors (TFs) in the T-cells of HL involved tissues in order to assess the nature of the T-H immune response in HL. Methods and results: By immunohistochemistry, GATA3 was strongly and T-bet exclusively expressed in a subset of interfollicular lymphocytes in the reactive lymphoid tissues. In classical HL (CHL), which is generally located in the interfollicular zones, a predominance...
Cigdem Atayar, Anke van den Berg, Tjasso Blokzijl, Marcel Boot, Randy D. Gascoyne, Lydia Visser, Sibrand Poppema
5 ‘-UTR FAS mutation pattern and frequency in nodal diffuse large B-cell lymphoma similar to normal germinal center B cells
Published in: Leukemia and Lymphoma
Strongly enhanced IL-10 production using stable galectin-1 homodimers
Published in: Molecular Immunology
Galectin-1 is the homodimeric form of a protein, which is present in a dynamic equilibrium with the beta-galactoside monomeric form and has potent anti-inflammatory and immunomodulating effects. These favorable effects are probably related to the induction of apoptosis in activated T cells and the induction of IL-10, which have been demonstrated to be characteristic for the dimeric form of the protein. Based on these findings it can be speculated that the in vivo effects of galectin-1 can be improved by the generation of stable galectin-1 homodimers (dGal). To...
Judith van der Leij, Anke van den Berg, Geert Harms, Hugo Eschbach, Hans Vos, Peter Zwiers, Rob van Weeghel, Herman Groen, Sibrand Poppema, Lydia Visser
Anti-CD45RB monoclonal antibody prolongs renal allograft survival in cynomolgus monkeys
Published in: American Journal of Transplantation
Previously, an anti-CD45RB monoclonal antibody (mAb) has been shown to induce murine allograft tolerance. The present study was performed to assess the ability of an anti-human CD45RB mAb to prevent rejection in a monkey MHC-mismatched kidney transplant model. The recipients were allocated into the following treatment groups: (1) isotype control IgG; (2) mouse anti-human CD45RB IgG1 (6G3); (3) human-mouse chimeric anti-CD45RB-IgG1 (C6G3-IgG1); (4) human-mouse chimeric anti-CD45RB-IgG2 (C6G3-IgG2); (5) tacrolimus at a subtherapeutic dose and (6) tacrolimus and C6G3-IgG1 in combination. Monotherapy with anti-CD45RB mAb significantly prolonged renal allograft...
G. Chen, P. P. W. Luke, H. Yang, L. Visser, H. Sun, B. Garcia, H. Qian, Y. Xiang, X. Huang, W. Liu, G. Senaldi, A. Schneider, S. Poppema, H. Wang, A. M. Jevnikar, R. Zhong
Gene expression analysis of dendritic/Langerhans cells and Langerhans cell histiocytosis
Published in: The Journal of Pathology
Langerhans cell histiocytosis (LCH) is a neoplastic disorder that results in clonal proliferation of cells with a Langerhans cell (LQ phenotype. The pathogenesis of LCH is still poorly understood. In the present study, serial analysis of gene expression (SAGE) was applied to LCs generated from umbilical cord blood CD34+ progenitor cells to identify LC-specific genes and the expression of these genes in LCH was investigated. Besides the expression of several genes known to be highly expressed in LCs and LCH such as CD1a, LYZ, and CD207, high expression...
Renata Rust, J. Kluiver, Lydia Visser, G. Harms, T. Blokzijl, W.A. Kamps, Sibrand Poppema, Anke van den Berg